Outpatient percutaneous central venous access in cancer patients

J. Ralph Broadwater, Michael A. Henderson, John Bell, Michael J. Edwards, G. Jeffrey Smith, David R. McCready, Richard S. Swanson, Mark E.R. Hardy, Robert R. Shenk, Millie Lawson, David M. Ota, Charles M. Balch

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

A 1-year experience of percutaneous subclavian catheterization in outpatients with cancer was reviewed to document reliability, safety, and cost. There were 763 catheter insertions attempted with prospective documentation of complications in 664 consecutive patients. Catheter insertion was successful in 722 attempts (95%). There were only 13 pneumothoraces (2%). Thiry catheters required repositioning (4%). The average catheter duration was 191 days (range: 0 to 892 days). Fifty-six catheters (8%) were removed because of suspected infection. Documented catheter sepsis occurred in 21 patients (3%); catheter site infection occurred in 8 patients (1%). Thus, only 0.22 infections per catheter year occurred during this 382 catheter-year experience. The estimated cost of catheter insertion was $562, which is one-third the estimated cost for tunneled catheters ($1,403) and for reservoir devices ($1,738). In our experience, percutaneous subclavian catheterization is a reliable, cost-effective method compared with tunneled or reservoir devices, with an equivalent incidence of catheter-related infections. The cornerstone of our success with this program is a staff dedicated to catheter care and intensive patient education. In centers where a large number of patients require central venous access, percutaneous catheterization should be the technique of choice.

Original languageEnglish (US)
Pages (from-to)676-680
Number of pages5
JournalThe American Journal of Surgery
Volume160
Issue number6
DOIs
StatePublished - Jan 1 1990

Fingerprint

Outpatients
Catheters
Neoplasms
Catheterization
Costs and Cost Analysis
Infection
Catheter-Related Infections
Equipment and Supplies
Pneumothorax
Patient Education
Critical Care
Documentation
Sepsis
Safety
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Broadwater, J. R., Henderson, M. A., Bell, J., Edwards, M. J., Smith, G. J., McCready, D. R., ... Balch, C. M. (1990). Outpatient percutaneous central venous access in cancer patients. The American Journal of Surgery, 160(6), 676-680. https://doi.org/10.1016/S0002-9610(05)80773-1

Outpatient percutaneous central venous access in cancer patients. / Broadwater, J. Ralph; Henderson, Michael A.; Bell, John; Edwards, Michael J.; Smith, G. Jeffrey; McCready, David R.; Swanson, Richard S.; Hardy, Mark E.R.; Shenk, Robert R.; Lawson, Millie; Ota, David M.; Balch, Charles M.

In: The American Journal of Surgery, Vol. 160, No. 6, 01.01.1990, p. 676-680.

Research output: Contribution to journalArticle

Broadwater, JR, Henderson, MA, Bell, J, Edwards, MJ, Smith, GJ, McCready, DR, Swanson, RS, Hardy, MER, Shenk, RR, Lawson, M, Ota, DM & Balch, CM 1990, 'Outpatient percutaneous central venous access in cancer patients', The American Journal of Surgery, vol. 160, no. 6, pp. 676-680. https://doi.org/10.1016/S0002-9610(05)80773-1
Broadwater JR, Henderson MA, Bell J, Edwards MJ, Smith GJ, McCready DR et al. Outpatient percutaneous central venous access in cancer patients. The American Journal of Surgery. 1990 Jan 1;160(6):676-680. https://doi.org/10.1016/S0002-9610(05)80773-1
Broadwater, J. Ralph ; Henderson, Michael A. ; Bell, John ; Edwards, Michael J. ; Smith, G. Jeffrey ; McCready, David R. ; Swanson, Richard S. ; Hardy, Mark E.R. ; Shenk, Robert R. ; Lawson, Millie ; Ota, David M. ; Balch, Charles M. / Outpatient percutaneous central venous access in cancer patients. In: The American Journal of Surgery. 1990 ; Vol. 160, No. 6. pp. 676-680.
@article{e3ea726e64a8443e89e02ecb9a88c2f2,
title = "Outpatient percutaneous central venous access in cancer patients",
abstract = "A 1-year experience of percutaneous subclavian catheterization in outpatients with cancer was reviewed to document reliability, safety, and cost. There were 763 catheter insertions attempted with prospective documentation of complications in 664 consecutive patients. Catheter insertion was successful in 722 attempts (95{\%}). There were only 13 pneumothoraces (2{\%}). Thiry catheters required repositioning (4{\%}). The average catheter duration was 191 days (range: 0 to 892 days). Fifty-six catheters (8{\%}) were removed because of suspected infection. Documented catheter sepsis occurred in 21 patients (3{\%}); catheter site infection occurred in 8 patients (1{\%}). Thus, only 0.22 infections per catheter year occurred during this 382 catheter-year experience. The estimated cost of catheter insertion was $562, which is one-third the estimated cost for tunneled catheters ($1,403) and for reservoir devices ($1,738). In our experience, percutaneous subclavian catheterization is a reliable, cost-effective method compared with tunneled or reservoir devices, with an equivalent incidence of catheter-related infections. The cornerstone of our success with this program is a staff dedicated to catheter care and intensive patient education. In centers where a large number of patients require central venous access, percutaneous catheterization should be the technique of choice.",
author = "Broadwater, {J. Ralph} and Henderson, {Michael A.} and John Bell and Edwards, {Michael J.} and Smith, {G. Jeffrey} and McCready, {David R.} and Swanson, {Richard S.} and Hardy, {Mark E.R.} and Shenk, {Robert R.} and Millie Lawson and Ota, {David M.} and Balch, {Charles M.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1016/S0002-9610(05)80773-1",
language = "English (US)",
volume = "160",
pages = "676--680",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Outpatient percutaneous central venous access in cancer patients

AU - Broadwater, J. Ralph

AU - Henderson, Michael A.

AU - Bell, John

AU - Edwards, Michael J.

AU - Smith, G. Jeffrey

AU - McCready, David R.

AU - Swanson, Richard S.

AU - Hardy, Mark E.R.

AU - Shenk, Robert R.

AU - Lawson, Millie

AU - Ota, David M.

AU - Balch, Charles M.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - A 1-year experience of percutaneous subclavian catheterization in outpatients with cancer was reviewed to document reliability, safety, and cost. There were 763 catheter insertions attempted with prospective documentation of complications in 664 consecutive patients. Catheter insertion was successful in 722 attempts (95%). There were only 13 pneumothoraces (2%). Thiry catheters required repositioning (4%). The average catheter duration was 191 days (range: 0 to 892 days). Fifty-six catheters (8%) were removed because of suspected infection. Documented catheter sepsis occurred in 21 patients (3%); catheter site infection occurred in 8 patients (1%). Thus, only 0.22 infections per catheter year occurred during this 382 catheter-year experience. The estimated cost of catheter insertion was $562, which is one-third the estimated cost for tunneled catheters ($1,403) and for reservoir devices ($1,738). In our experience, percutaneous subclavian catheterization is a reliable, cost-effective method compared with tunneled or reservoir devices, with an equivalent incidence of catheter-related infections. The cornerstone of our success with this program is a staff dedicated to catheter care and intensive patient education. In centers where a large number of patients require central venous access, percutaneous catheterization should be the technique of choice.

AB - A 1-year experience of percutaneous subclavian catheterization in outpatients with cancer was reviewed to document reliability, safety, and cost. There were 763 catheter insertions attempted with prospective documentation of complications in 664 consecutive patients. Catheter insertion was successful in 722 attempts (95%). There were only 13 pneumothoraces (2%). Thiry catheters required repositioning (4%). The average catheter duration was 191 days (range: 0 to 892 days). Fifty-six catheters (8%) were removed because of suspected infection. Documented catheter sepsis occurred in 21 patients (3%); catheter site infection occurred in 8 patients (1%). Thus, only 0.22 infections per catheter year occurred during this 382 catheter-year experience. The estimated cost of catheter insertion was $562, which is one-third the estimated cost for tunneled catheters ($1,403) and for reservoir devices ($1,738). In our experience, percutaneous subclavian catheterization is a reliable, cost-effective method compared with tunneled or reservoir devices, with an equivalent incidence of catheter-related infections. The cornerstone of our success with this program is a staff dedicated to catheter care and intensive patient education. In centers where a large number of patients require central venous access, percutaneous catheterization should be the technique of choice.

UR - http://www.scopus.com/inward/record.url?scp=0025666395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025666395&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(05)80773-1

DO - 10.1016/S0002-9610(05)80773-1

M3 - Article

VL - 160

SP - 676

EP - 680

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 6

ER -